Page 2 - Pathogenesis Program News Today

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

Scientists at Memorial Sloan Kettering Cancer Center (MSK) have glimpsed never-before-seen details of the human androgen receptor -; the protein inside of cells that responds to male-typical hormones like testosterone.

UNSW academics, alumni, colleagues, former colleagues and community members have been recognised in this year’s Australia Day Honours.Professor John Alexander Church, Professor of Oceans, Climate and Sea-level, Climate Change Research Centre (CCRC) a

Investegate announcements from Quidel Corporation, Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation

DGAP-News: Quidel Corporation Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation 02.11.2021 / 17:44 The issuer is solely responsible for the content of this announcement. Quidel Corporation announced today that it will serve as sponsor for the up...

DGAP-News: Quidel Corporation Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation 02.11.2021 / 17:44 The issuer is solely responsible

Scientists approached by China Daily would not be drawn on the politicization of COVID-19 and insist any investigation into the origins of the virus that causes the disease should be based on science.

49% of patients treated with Opdivo plus Yervoy were alive at 6.5 years and 77% of these patients remained treatment-free Data to be featured in an oral presentation during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Bristol Myers Squibb (NYSE: BMY) today announced new six-and-a-half-year data from CheckMate -067, a randomized, double-blind, Phase 3 clinical trial, demonstrating durable improvement in survival with first-line Opdivo (nivolumab) plus Opd...

NEW YORK – A team of U.S. scientists, led by an Indian American researcher, has identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. According to Sumit K. Chanda, professor and director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys Medical Discovery Institute, the scientists have gained new insights into how the virus exploits the human cells it invades. "We are still searching for its Achilles Heel so that we can develop opt...

Print Scientists at the Sanford Burnham Prebys Medical Discovery Institute in La Jolla have identified a set of human genes that fight SARS-CoV-2, the virus that causes COVID-19. Knowing which genes help control viral infection can greatly assist researchers’ understanding of factors that affect disease severity and also suggest possible therapeutic options. The genes in question are related to interferons, the body’s frontline virus fighters. “We wanted to gain a better understanding o...